Horrell Capital Management’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Horrell Capital Management’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,500	Closed	-$1K	–	199
2016 Q2	$1K	Buy	+1,500	New	+$2.41K	﹤0.01%	188

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Horrell Capital Management's EPRS Position: Q3 2016 in Review

Horrell Capital Management sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 1,500 shares — an estimated $1K sold.

Horrell Capital Management first reported a position in EPRS in Q2 2016 and held it in 1 quarter. The position peaked at $1K in Q2 2016. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Horrell Capital Management reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Horrell Capital Management sold 1,500 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016, an estimated $1K.
Horrell Capital Management first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q2 2016 and held it in 1 quarter.
Horrell Capital Management's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $1K in Q2 2016.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Horrell Capital Management's 13F filing for Q3 2016, filed 20 Oct 2016.